Is asthma a vanishing disease? A study to forecast the burden of asthma in 2022

被引:21
|
作者
To, Teresa [1 ,2 ,3 ]
Stanojevic, Sanja [1 ,3 ]
Feldman, Rachel [1 ]
Moineddin, Rahim [2 ,3 ]
Atenafu, Eshetu G. [4 ]
Guan, Jun [2 ]
Gershon, Andrea S. [2 ,3 ]
机构
[1] Hosp Sick Children, Toronto, ON M5G 1X8, Canada
[2] Inst Clin Evaluat Sci, Toronto, ON M4N 3M5, Canada
[3] Univ Toronto, Toronto, ON M5S 1A1, Canada
[4] Univ Hlth Network, Toronto, ON M5G 2C4, Canada
来源
BMC PUBLIC HEALTH | 2013年 / 13卷
基金
加拿大健康研究院;
关键词
PHYSICIAN-DIAGNOSED ASTHMA; CHILDHOOD ASTHMA; PREVALENCE; CANADA; TRENDS; EPIDEMIOLOGY; MORBIDITY; CHILDREN; WEIGHT; GENDER;
D O I
10.1186/1471-2458-13-254
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Recent evidence regarding temporal trends of asthma burden has not been consistent, with some countries reporting decreases in prevalence of asthma. In Ontario, the province in Canada with the highest population, the prevalence of asthma rose at a rate of 0.5% per year between 1996 and 2005. These estimates were based on population-based health services use data spanning more than a decade and provide a powerful source to forecast the trends of asthma burden. The objective of this study was to use observed population trends data of asthma incidence and prevalence to forecast future disease burden. Methods: The Ontario Asthma Surveillance Information System (OASIS) used health administrative databases to identify and track all individuals in the province with asthma. Individuals with asthma identified between April 1, 1996 and March 31, 2010 were included. Exponential smoothing models were applied to annual data to project incidence to the year 2022, prevalence was estimated by applying the cumulative projected incidence to the projected population. Results: While asthma incidence is falling, the absolute number of prevalent cases will continue to rise. We projected that almost 1 in 8 individuals in Ontario will have asthma by the year 2022, suggesting that asthma will continue to be a major burden on individuals and the health care system. Conclusions: These projections will help inform health care planners and decision-makers regarding resource allocation to optimize asthma outcomes.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Global associations of macronutrient supply and asthma disease burden
    Ni, Duan
    Senior, Alistair
    Raubenheimer, David
    Simpson, Stephen
    Macia, Laurence
    Nanan, Ralph
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2024, 54 : 566 - 566
  • [32] Treatment Patterns and Disease Burden of Triple Therapy in Asthma
    Bogart, M.
    Chastek, B.
    White, J.
    Sundquist, K.
    Averell, C. M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [33] Burden of disease in both asthma and COPD: one questionnaire?
    Cuperus, L.
    Van Zelst, C.
    Braunstahl, G.
    Veen, J. In'T
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [34] Disease burden in individuals with symptomatic undiagnosed asthma or COPD
    Alhabeeb, Fatmah F.
    Whitmore, G. A.
    Vandemheen, Katherine L.
    FitzGerald, J. Mark
    Bergeron, Celine
    Lemiere, Catherine
    Boulet, Louis-Philippe
    Field, Stephen K.
    Penz, Erika
    McIvor, R. Andrew
    Gupta, Samir
    Mayers, Irvin
    Bhutani, Mohit
    Hernandez, Paul
    Lougheed, Diane
    Licskai, Christopher J.
    Azher, Tanweer
    Cote, Andreanne
    Ainslie, Martha
    Fraser, Ian
    Mahdavian, Masoud
    Aaron, Shawn D.
    RESPIRATORY MEDICINE, 2022, 200
  • [35] Dupilumab reduces asthma disease burden and recurrent SCS use in patients with CRSwNP and coexisting asthma
    Gurnell, Mark
    Menzies-Gow, Andrew
    Bachert, Claus
    Lugogo, Njira
    Cho, Seong
    Siddiqui, Shahid
    Nash, Scott
    Zhang, Haixin
    Khan, Asif
    Nara, Juby Jacob
    Rowe, Paul
    Deniz, Yamo
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (02) : AB125 - AB125
  • [36] Dupilumab Reduces Asthma Disease Burden and Recurrent SCS Use in Patients with CRSwNP and Coexisting Asthma
    Gurnell, Mark
    Radwan, Amr
    Bachert, Claus
    Lugogo, Njira
    Cho, Seong H.
    Nash, Scott
    Zhang, Haixin
    Khan, Asif H.
    Jacob-Nara, Juby A.
    Rowe, Paul J.
    Deniz, Yamo
    JOURNAL OF ASTHMA AND ALLERGY, 2024, 17 : 1 - 8
  • [37] Vanishing lung mass in a patient with asthma
    Madan, Karan
    Guleria, Randeep
    JOURNAL OF THORACIC DISEASE, 2013, 5 (02) : E45 - E49
  • [38] Current burden of uncontrolled asthma in the general population: The OPCRD asthma state of the union study
    Thomas, Mike
    Nibber, Anjan
    van Aaleren, Wim
    Bleecker, Eugene
    Campbell, Jonathan
    Roche, Nicolas
    Haughney, John
    Van Ganse, Eric
    Park, Hye-Yun
    Rhee, Chin Kook
    Skinner, Derek
    Chisholm, Alison
    van Boven, Job
    Bonomally, Rosalind
    Thomas, Vicky
    Soriano, Joan
    Price, David
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [39] Impact of the Asthma Quality Assessment Program on Burden of Asthma
    Park, Hye Jung
    Kim, Sung-Ryeol
    Kim, Sinae
    Lee, Hye Sun
    Kim, Bo Yeon
    Kim, Hye Kyoung
    Ahn, Sang In
    Shin, Ji Hyeon
    Lee, Jae-Hyun
    Park, Jung-Won
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2021, 9 (01): : 419 - 425.e6
  • [40] Asthma patients' and physicians' perspectives on the burden and management of asthma
    Chapman, Kenneth R.
    An, Li
    Bosnic-Anticevich, Sinthia
    Campomanes, Celeste M.
    Espinosa, Jeronimo
    Jain, Priya
    Lavoie, Kim L.
    Li, Jing
    Butta, Aman K.
    RESPIRATORY MEDICINE, 2021, 186